Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer.
The treatment paradigm for early stage lung cancer and oligometastatic disease to the lung is rapidly changing. Ablative therapies, especially stereotactic body radiation therapy, are challenging the surgical gold standard and have the potential to be the standard for operable patients with early stage lung cancer who are high risk due to co- morbidities. The most commonly used ablative modalities include stereotactic body radiation therapy, microwave ablation, and radiofrequency ablation.
Minimally Invasive Thoracic Surgery, Meridian Health, 1 Riverview Plaza, Red Bank, NJ 07701, USA. Electronic address: gabbas@meridianhealth.com.
Ghulam
G
Abbas
Radiation Oncology, Meridian Health, 1 Riverview Plaza, Red Bank, NJ 07701, USA.
Adnan
A
Danish
Meridian Cancer Care, Jersey Shore University Medical Center, Ackerman South, Room 553, 1945 Route 33, Neptune, NJ 07753, USA.
Mark J
MJ
Krasna
D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology* / Q000601:surgery*; D017115:Catheter Ablation; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology* / Q000601:surgery*; D011853:Radiobiology; D016634:Radiosurgery / Q000009:adverse effects / Q000379:methods*; D012720:Severity of Illness Index; D016896:Treatment Outcome
Ablative therapies for lung cancer; Microwave ablation; Radiofrequency ablation; Stereotactic ablative therapy (SABR); Stereotactic body radiation therapy (SBRT)